Transaction · 0001231919-26-000457
COAGHemab Therapeutics Holdings, Inc.
Ra Capital Management, L.P.
RA CAPITAL MANAGEMENT, L.P., DIR, reported a transaction classified as unknown at Hemab Therapeutics Holdings, Inc. involving 18146.000000 shares. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
unknownSEC transaction code CDIR
- Trade date
- May 04, 2026
- Filing date
- May 06, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingmissing priceThe filing did not provide a usable price per share.
COAG price since this filing
Daily closing prices, with the filing date and available return windowsCOAG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- unknown Code C
- Identifier
- 0001231919-26-000457 Series B Preferred Stock
- Transaction date
- May 04, 2026 Filed May 06, 2026, 11:16 PM · 2d delay
- Shares
- 18,146 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 0 sh Indirect · See footnotes
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
Low filing signal
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
Missing facts
Read the scoring methodology- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% YesOther No
Footnotes & amended
- F1
Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initi…
- F2
RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus II Fund, L.P. (the "Nexus Fund II") and RA Capital Nexus IV Fu…
- F3
Held directly by the Fund.
- F4
Held directly by Nexus Fund II.
- F5
Held directly by Nexus Fund IV.
- F6
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.9994 inclusive. The Reporting Persons undertake to…
- F7
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.495 to $24.455 inclusive. The Reporting Persons undertake to…
- F8
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.505 to $25.00 inclusive. The Reporting Persons undertake to…
Related transactions
Same SEC filing0 other transactions
Recent company activity
COAG0 recent txs